APO Research
Talk to an analyst

APO RESEARCH · REPORT

Granulocyte Macrophage Colony Stimulating Factor

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Granulocyte Macrophage Colony Stimulating Factor Market Analysis and Forecast 2026-2032

19 December 2025197 pages

Choose your research edition.

Industry ResearchGranulocyte Macrophage Colony Stimulating Factor Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Granulocyte Macrophage Colony Stimulating Factor Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Granulocyte Macrophage Colony Stimulating Factor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Granulocyte Macrophage Colony Stimulating Factor Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Granulocyte Macrophage Colony Stimulating Factor Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Granulocyte Macrophage Colony Stimulating Factor market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Granulocyte Macrophage Colony Stimulating Factor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Granulocyte Macrophage Colony Stimulating Factor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Granulocyte Macrophage Colony Stimulating Factor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Granulocyte Macrophage Colony Stimulating Factor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Granulocyte Macrophage Colony Stimulating Factor include Takeda Pharmaceutical Co Ltd, GlaxoSmithKline Plc, Amgen Inc, Sillajen Biotherapeutics, Morphotek Inc, Mologen AG, Humanigen Inc, Cold Genesys Inc and BriaCell Therapeutics Corp, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Granulocyte Macrophage Colony Stimulating Factor, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Granulocyte Macrophage Colony Stimulating Factor, also provides the sales of main regions and countries. Of the upcoming market potential for Granulocyte Macrophage Colony Stimulating Factor, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Granulocyte Macrophage Colony Stimulating Factor sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Granulocyte Macrophage Colony Stimulating Factor market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Granulocyte Macrophage Colony Stimulating Factor sales, projected growth trends, production technology, application and end-user industry.

Granulocyte Macrophage Colony Stimulating Factor Segment by Company

Takeda Pharmaceutical Co Ltd

GlaxoSmithKline Plc

Amgen Inc

Sillajen Biotherapeutics

Morphotek Inc

Mologen AG

Humanigen Inc

Cold Genesys Inc

BriaCell Therapeutics Corp

Aduro BioTech Inc

Granulocyte Macrophage Colony Stimulating Factor Segment by Type

CG-0070

Lenzilumab

Gimsilumab

MGN-1601

GSK-3196165

Others

Granulocyte Macrophage Colony Stimulating Factor Segment by Application

Solid Tumor

Kidney Cancer

Lymphoma

Lung Disease

Others

Granulocyte Macrophage Colony Stimulating Factor Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Granulocyte Macrophage Colony Stimulating Factor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Granulocyte Macrophage Colony Stimulating Factor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Granulocyte Macrophage Colony Stimulating Factor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Granulocyte Macrophage Colony Stimulating Factor in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Granulocyte Macrophage Colony Stimulating Factor manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Granulocyte Macrophage Colony Stimulating Factor sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. CG-0070 Major Manufacturers Table 3. Lenzilumab Major Manufacturers Table 4. Gimsilumab Major Manufacturers Table 5. MGN-1601 Major Manufacturers Table 6. GSK-3196165 Major Manufacturers Table 7. Others Major Manufacturers Table 8. Global Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Solid Tumor Major Manufacturers Table 10. Kidney Cancer Major Manufacturers Table 11. Lymphoma Major Manufacturers Table 12. Lung Disease Major Manufacturers Table 13. Others Major Manufacturers Table 14. Granulocyte Macrophage Colony Stimulating Factor Industry Trends Table 15. Granulocyte Macrophage Colony Stimulating Factor Industry Drivers Table 16. Granulocyte Macrophage Colony Stimulating Factor Industry Opportunities and Challenges Table 17. Granulocyte Macrophage Colony Stimulating Factor Industry Restraints Table 18. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Region (2021-2026) & (US$ Million) Table 20. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Region (2027-2032) & (US$ Million) Table 21. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Region (2021-2026) Table 22. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Region (2027-2032) Table 23. Global Granulocyte Macrophage Colony Stimulating Factor Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 24. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Region (2021-2026) & (K Units) Table 25. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Region (2027-2032) & (K Units) Table 26. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region (2021-2026) Table 27. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region (2027-2032) Table 28. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Manufacturers (2021-2026) Table 30. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Manufacturers (US$ Million) & (2021-2026) Table 31. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Manufacturers (2021-2026) Table 32. Global Granulocyte Macrophage Colony Stimulating Factor Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 33. Global Granulocyte Macrophage Colony Stimulating Factor Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 34. Global Granulocyte Macrophage Colony Stimulating Factor Key Manufacturers Manufacturing Sites & Headquarters Table 35. Global Granulocyte Macrophage Colony Stimulating Factor Manufacturers, Product Type & Application Table 36. Global Granulocyte Macrophage Colony Stimulating Factor Manufacturers' Establishment Date Table 37. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 38. Global Granulocyte Macrophage Colony Stimulating Factor by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Type (2021-2026) & (US$ Million) Table 41. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Type (2027-2032) & (US$ Million) Table 42. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Type (2021-2026) Table 43. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Type (2027-2032) Table 44. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 45. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021-2026) & (K Units) Table 46. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2027-2032) & (K Units) Table 47. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2021-2026) Table 48. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2027-2032) Table 49. Global Granulocyte Macrophage Colony Stimulating Factor Price by Type (2021-2026) & (US$/Unit) Table 50. Global Granulocyte Macrophage Colony Stimulating Factor Price by Type (2027-2032) & (US$/Unit) Table 51. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Application (2021-2026) & (US$ Million) Table 53. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Application (2027-2032) & (US$ Million) Table 54. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Application (2021-2026) Table 55. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Application (2027-2032) Table 56. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 57. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021-2026) & (K Units) Table 58. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2027-2032) & (K Units) Table 59. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2021-2026) Table 60. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2027-2032) Table 61. Global Granulocyte Macrophage Colony Stimulating Factor Price by Application (2021-2026) & (US$/Unit) Table 62. Global Granulocyte Macrophage Colony Stimulating Factor Price by Application (2027-2032) & (US$/Unit) Table 63. Takeda Pharmaceutical Co Ltd Company Information Table 64. Takeda Pharmaceutical Co Ltd Business Overview Table 65. Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Product Portfolio Table 67. Takeda Pharmaceutical Co Ltd Recent Development Table 68. GlaxoSmithKline Plc Company Information Table 69. GlaxoSmithKline Plc Business Overview Table 70. GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Product Portfolio Table 72. GlaxoSmithKline Plc Recent Development Table 73. Amgen Inc Company Information Table 74. Amgen Inc Business Overview Table 75. Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolio Table 77. Amgen Inc Recent Development Table 78. Sillajen Biotherapeutics Company Information Table 79. Sillajen Biotherapeutics Business Overview Table 80. Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Product Portfolio Table 82. Sillajen Biotherapeutics Recent Development Table 83. Morphotek Inc Company Information Table 84. Morphotek Inc Business Overview Table 85. Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolio Table 87. Morphotek Inc Recent Development Table 88. Mologen AG Company Information Table 89. Mologen AG Business Overview Table 90. Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Mologen AG Granulocyte Macrophage Colony Stimulating Factor Product Portfolio Table 92. Mologen AG Recent Development Table 93. Humanigen Inc Company Information Table 94. Humanigen Inc Business Overview Table 95. Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolio Table 97. Humanigen Inc Recent Development Table 98. Cold Genesys Inc Company Information Table 99. Cold Genesys Inc Business Overview Table 100. Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolio Table 102. Cold Genesys Inc Recent Development Table 103. BriaCell Therapeutics Corp Company Information Table 104. BriaCell Therapeutics Corp Business Overview Table 105. BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Product Portfolio Table 107. BriaCell Therapeutics Corp Recent Development Table 108. Aduro BioTech Inc Company Information Table 109. Aduro BioTech Inc Business Overview Table 110. Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolio Table 112. Aduro BioTech Inc Recent Development Table 113. North America Granulocyte Macrophage Colony Stimulating Factor Revenue by Type (2021-2026) & (US$ Million) Table 114. North America Granulocyte Macrophage Colony Stimulating Factor Revenue by Type (2027-2032) & (US$ Million) Table 115. North America Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021-2026) & (K Units) Table 116. North America Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2027-2032) & (K Units) Table 117. North America Granulocyte Macrophage Colony Stimulating Factor Sales Price by Type (2021-2026) & (US$/Unit) Table 118. North America Granulocyte Macrophage Colony Stimulating Factor Sales Price by Type (2027-2032) & (US$/Unit) Table 119. North America Granulocyte Macrophage Colony Stimulating Factor Revenue by Application (2021-2026) & (US$ Million) Table 120. North America Granulocyte Macrophage Colony Stimulating Factor Revenue by Application (2027-2032) & (US$ Million) Table 121. North America Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021-2026) & (K Units) Table 122. North America Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2027-2032) & (K Units) Table 123. North America Granulocyte Macrophage Colony Stimulating Factor Sales Price by Application (2021-2026) & (US$/Unit) Table 124. North America Granulocyte Macrophage Colony Stimulating Factor Sales Price by Application (2027-2032) & (US$/Unit) Table 125. North America Granulocyte Macrophage Colony Stimulating Factor Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. North America Granulocyte Macrophage Colony Stimulating Factor Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 127. North America Granulocyte Macrophage Colony Stimulating Factor Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 128. North America Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 129. North America Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2021-2026) & (K Units) Table 130. North America Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2027-2032) & (K Units) Table 131. North America Granulocyte Macrophage Colony Stimulating Factor Sales Price by Country (2021-2026) & (US$/Unit) Table 132. North America Granulocyte Macrophage Colony Stimulating Factor Sales Price by Country (2027-2032) & (US$/Unit) Table 133. United States Granulocyte Macrophage Colony Stimulating Factor Revenue (2021-2032) & (US$ Million) Table 134. Canada Granulocyte Macrophage Colony Stimulating Factor Revenue (2021-2032) & (US$ Million) Table 135. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue by Type (2021-2026) & (US$ Million) Table 136. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue by Type (2027-2032) & (US$ Million) Table 137. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021-2026) & (K Units) Table 138. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2027-2032) & (K Units) Table 139. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Price by Type (2021-2026) & (US$/Unit) Table 140. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Price by Type (2027-2032) & (US$/Unit) Table 141. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue by Application (2021-2026) & (US$ Million) Table 142. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue by Application (2027-2032) & (US$ Million) Table 143. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021-2026) & (K Units) Table 144. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2027-2032) & (K Units) Table 145. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Price by Application (2021-2026) & (US$/Unit) Table 146. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Price by Application (2027-2032) & (US$/Unit) Table 147. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 151. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2021-2026) & (K Units) Table 152. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2027-2032) & (K Units) Table 153. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Price by Country (2021-2026) & (US$/Unit) Table 154. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Price by Country (2027-2032) & (US$/Unit) Table 155. Germany Granulocyte Macrophage Colony Stimulating Factor Revenue (2021-2032) & (US$ Million) Table 156. France Granulocyte Macrophage Colony Stimulating Factor Revenue (2021-2032) & (US$ Million) Table 157. U.K. Granulocyte Macrophage Colony Stimulating Factor Revenue (2021-2032) & (US$ Million) Table 158. Italy Granulocyte Macrophage Colony Stimulating Factor Revenue (2021-2032) & (US$ Million) Table 159. Netherlands Granulocyte Macrophage Colony Stimulating Factor Revenue (2021-2032) & (US$ Million) Table 160. China Granulocyte Macrophage Colony Stimulating Factor Revenue by Type (2021-2026) & (US$ Million) Table 161. China Granulocyte Macrophage Colony Stimulating Factor Revenue by Type (2027-2032) & (US$ Million) Table 162. China Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021-2026) & (K Units) Table 163. China Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2027-2032) & (K Units) Table 164. China Granulocyte Macrophage Colony Stimulating Factor Sales Price by Type (2021-2026) & (US$/Unit) Table 165. China Granulocyte Macrophage Colony Stimulating Factor Sales Price by Type (2027-2032) & (US$/Unit) Table 166. China Granulocyte Macrophage Colony Stimulating Factor Revenue by Application (2021-2026) & (US$ Million) Table 167. China Granulocyte Macrophage Colony Stimulating Factor Revenue by Application (2027-2032) & (US$ Million) Table 168. China Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021-2026) & (K Units) Table 169. China Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2027-2032) & (K Units) Table 170. China Granulocyte Macrophage Colony Stimulating Factor Sales Price by Application (2021-2026) & (US$/Unit) Table 171. China Granulocyte Macrophage Colony Stimulating Factor Sales Price by Application (2027-2032) & (US$/Unit) Table 172. Asia Granulocyte Macrophage Colony Stimulating Factor Revenue by Type (2021-2026) & (US$ Million) Table 173. Asia Granulocyte Macrophage Colony Stimulating Factor Revenue by Type (2027-2032) & (US$ Million) Table 174. Asia Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021-2026) & (K Units) Table 175. Asia Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2027-2032) & (K Units) Table 176. Asia Granulocyte Macrophage Colony Stimulating Factor Sales Price by Type (2021-2026) & (US$/Unit) Table 177. Asia Granulocyte Macrophage Colony Stimulating Factor Sales Price by Type (2027-2032) & (US$/Unit) Table 178. Asia Granulocyte Macrophage Colony Stimulating Factor Revenue by Application (2021-2026) & (US$ Million) Table 179. Asia Granulocyte Macrophage Colony Stimulating Factor Revenue by Application (2027-2032) & (US$ Million) Table 180. Asia Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021-2026) & (K Units) Table 181. Asia Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2027-2032) & (K Units) Table 182. Asia Granulocyte Macrophage Colony Stimulating Factor Sales Price by Application (2021-2026) & (US$/Unit) Table 183. Asia Granulocyte Macrophage Colony Stimulating Factor Sales Price by Application (2027-2032) & (US$/Unit) Table 184. Asia Granulocyte Macrophage Colony Stimulating Factor Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. Asia Granulocyte Macrophage Colony Stimulating Factor Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. Asia Granulocyte Macrophage Colony Stimulating Factor Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. Asia Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 188. Asia Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2021-2026) & (K Units) Table 189. Asia Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2027-2032) & (K Units) Table 190. Asia Granulocyte Macrophage Colony Stimulating Factor Sales Price by Country (2021-2026) & (US$/Unit) Table 191. Asia Granulocyte Macrophage Colony Stimulating Factor Sales Price by Country (2027-2032) & (US$/Unit) Table 192. Japan Granulocyte Macrophage Colony Stimulating Factor Revenue (2021-2032) & (US$ Million) Table 193. South Korea Granulocyte Macrophage Colony Stimulating Factor Revenue (2021-2032) & (US$ Million) Table 194. India Granulocyte Macrophage Colony Stimulating Factor Revenue (2021-2032) & (US$ Million) Table 195. Australia Granulocyte Macrophage Colony Stimulating Factor Revenue (2021-2032) & (US$ Million) Table 196. China Taiwan Granulocyte Macrophage Colony Stimulating Factor Revenue (2021-2032) & (US$ Million) Table 197. Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Revenue (2021-2032) & (US$ Million) Table 198. SAMEA Granulocyte Macrophage Colony Stimulating Factor Revenue by Type (2021-2026) & (US$ Million) Table 199. SAMEA Granulocyte Macrophage Colony Stimulating Factor Revenue by Type (2027-2032) & (US$ Million) Table 200. SAMEA Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021-2026) & (K Units) Table 201. SAMEA Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2027-2032) & (K Units) Table 202. SAMEA Granulocyte Macrophage Colony Stimulating Factor Sales Price by Type (2021-2026) & (US$/Unit) Table 203. SAMEA Granulocyte Macrophage Colony Stimulating Factor Sales Price by Type (2027-2032) & (US$/Unit) Table 204. SAMEA Granulocyte Macrophage Colony Stimulating Factor Revenue by Application (2021-2026) & (US$ Million) Table 205. SAMEA Granulocyte Macrophage Colony Stimulating Factor Revenue by Application (2027-2032) & (US$ Million) Table 206. SAMEA Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021-2026) & (K Units) Table 207. SAMEA Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2027-2032) & (K Units) Table 208. SAMEA Granulocyte Macrophage Colony Stimulating Factor Sales Price by Application (2021-2026) & (US$/Unit) Table 209. SAMEA Granulocyte Macrophage Colony Stimulating Factor Sales Price by Application (2027-2032) & (US$/Unit) Table 210. SAMEA Granulocyte Macrophage Colony Stimulating Factor Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 211. SAMEA Granulocyte Macrophage Colony Stimulating Factor Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 212. SAMEA Granulocyte Macrophage Colony Stimulating Factor Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 213. SAMEA Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 214. SAMEA Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2021-2026) & (K Units) Table 215. SAMEA Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2027-2032) & (K Units) Table 216. SAMEA Granulocyte Macrophage Colony Stimulating Factor Sales Price by Country (2021-2026) & (US$/Unit) Table 217. SAMEA Granulocyte Macrophage Colony Stimulating Factor Sales Price by Country (2027-2032) & (US$/Unit) Table 218. Brazil Granulocyte Macrophage Colony Stimulating Factor Revenue (2021-2032) & (US$ Million) Table 219. Argentina Granulocyte Macrophage Colony Stimulating Factor Revenue (2021-2032) & (US$ Million) Table 220. Chile Granulocyte Macrophage Colony Stimulating Factor Revenue (2021-2032) & (US$ Million) Table 221. Colombia Granulocyte Macrophage Colony Stimulating Factor Revenue (2021-2032) & (US$ Million) Table 222. Peru Granulocyte Macrophage Colony Stimulating Factor Revenue (2021-2032) & (US$ Million) Table 223. Saudi Arabia Granulocyte Macrophage Colony Stimulating Factor Revenue (2021-2032) & (US$ Million) Table 224. Israel Granulocyte Macrophage Colony Stimulating Factor Revenue (2021-2032) & (US$ Million) Table 225. UAE Granulocyte Macrophage Colony Stimulating Factor Revenue (2021-2032) & (US$ Million) Table 226. Turkey Granulocyte Macrophage Colony Stimulating Factor Revenue (2021-2032) & (US$ Million) Table 227. Iran Granulocyte Macrophage Colony Stimulating Factor Revenue (2021-2032) & (US$ Million) Table 228. Egypt Granulocyte Macrophage Colony Stimulating Factor Revenue (2021-2032) & (US$ Million) Table 229. Key Raw Materials Table 230. Raw Materials Key Suppliers Table 231. Granulocyte Macrophage Colony Stimulating Factor Distributors List Table 232. Granulocyte Macrophage Colony Stimulating Factor Customers List Table 233. Research Programs/Design for This Report Table 234. Authors List of This Report Table 235. Secondary Sources Table 236. Primary Sources List of Figures Figure 1. Granulocyte Macrophage Colony Stimulating Factor Image Figure 2. Global Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Granulocyte Macrophage Colony Stimulating Factor Market Size Share 2021 VS 2025 VS 2032 Figure 4. CG-0070 Image Figure 5. Lenzilumab Image Figure 6. Gimsilumab Image Figure 7. MGN-1601 Image Figure 8. GSK-3196165 Image Figure 9. Others Image Figure 10. Global Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Granulocyte Macrophage Colony Stimulating Factor Market Size Share 2021 VS 2025 VS 2032 Figure 12. Solid Tumor Image Figure 13. Kidney Cancer Image Figure 14. Lymphoma Image Figure 15. Lung Disease Image Figure 16. Others Image Figure 17. Global Granulocyte Macrophage Colony Stimulating Factor Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Granulocyte Macrophage Colony Stimulating Factor Revenue (2021-2032) & (US$ Million) Figure 19. Global Granulocyte Macrophage Colony Stimulating Factor Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Region: 2025 Versus 2032 Figure 21. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Region (2021-2032) Figure 22. Global Granulocyte Macrophage Colony Stimulating Factor Sales (2021-2032) & (K Units) Figure 23. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 24. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region (2021-2032) Figure 25. US & Canada & Mexico Granulocyte Macrophage Colony Stimulating Factor Sales YoY (2021-2032) & (K Units) Figure 26. Europe Granulocyte Macrophage Colony Stimulating Factor Sales YoY (2021-2032) & (K Units) Figure 27. China Granulocyte Macrophage Colony Stimulating Factor Sales YoY (2021-2032) & (K Units) Figure 28. Asia (Excluding China) Granulocyte Macrophage Colony Stimulating Factor Sales YoY (2021-2032) & (K Units) Figure 29. South America, Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales YoY (2021-2032) & (K Units) Figure 30. Global Granulocyte Macrophage Colony Stimulating Factor Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 31. Global Granulocyte Macrophage Colony Stimulating Factor Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 32. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Type (2021-2032) Figure 36. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 38. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2021-2032) Figure 39. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 40. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Application (2021-2032) Figure 42. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 43. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 44. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2021-2032) Figure 45. North America Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Type (2021-2032) Figure 46. North America Granulocyte Macrophage Colony Stimulating Factor Sales Share by Type (2021-2032) Figure 47. North America Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Application (2021-2032) Figure 48. North America Granulocyte Macrophage Colony Stimulating Factor Sales Share by Application (2021-2032) Figure 49. North America Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Country (2021-2032) Figure 50. North America Granulocyte Macrophage Colony Stimulating Factor Sales Share by Country (2021-2032) Figure 51. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Type (2021-2032) Figure 52. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Share by Type (2021-2032) Figure 53. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Application (2021-2032) Figure 54. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Share by Application (2021-2032) Figure 55. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Country (2021-2032) Figure 56. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Share by Country (2021-2032) Figure 57. China Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Type (2021-2032) Figure 58. China Granulocyte Macrophage Colony Stimulating Factor Sales Share by Type (2021-2032) Figure 59. China Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Application (2021-2032) Figure 60. China Granulocyte Macrophage Colony Stimulating Factor Sales Share by Application (2021-2032) Figure 61. Asia Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Type (2021-2032) Figure 62. Asia Granulocyte Macrophage Colony Stimulating Factor Sales Share by Type (2021-2032) Figure 63. Asia Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Application (2021-2032) Figure 64. Asia Granulocyte Macrophage Colony Stimulating Factor Sales Share by Application (2021-2032) Figure 65. Asia Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Country (2021-2032) Figure 66. Asia Granulocyte Macrophage Colony Stimulating Factor Sales Share by Country (2021-2032) Figure 67. SAMEA Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Type (2021-2032) Figure 68. SAMEA Granulocyte Macrophage Colony Stimulating Factor Sales Share by Type (2021-2032) Figure 69. SAMEA Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Application (2021-2032) Figure 70. SAMEA Granulocyte Macrophage Colony Stimulating Factor Sales Share by Application (2021-2032) Figure 71. SAMEA Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Country (2021-2032) Figure 72. SAMEA Granulocyte Macrophage Colony Stimulating Factor Sales Share by Country (2021-2032) Figure 73. Granulocyte Macrophage Colony Stimulating Factor Value Chain Figure 74. Manufacturing Cost Structure Figure 75. Granulocyte Macrophage Colony Stimulating Factor Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Years Considered Figure 79. Research Process Figure 80. Key Executives Interviewed

Scope & coverage.

Types
  • CG-0070
  • Lenzilumab
  • Gimsilumab
  • MGN-1601
  • GSK-3196165
  • Others
Applications
  • Solid Tumor
  • Kidney Cancer
  • Lymphoma
  • Lung Disease
  • Others
Companies covered
  • Takeda Pharmaceutical Co Ltd
  • GlaxoSmithKline Plc
  • Amgen Inc
  • Sillajen Biotherapeutics
  • Morphotek Inc
  • Mologen AG
  • Humanigen Inc
  • Cold Genesys Inc
  • BriaCell Therapeutics Corp
  • Aduro BioTech Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Granulocyte Macrophage Colony Stimulating Factor Market by Type
  3. 1.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 CG-0070
  5. 1.2.3 Lenzilumab
  6. 1.2.4 Gimsilumab
  7. 1.2.5 MGN-1601
  8. 1.2.6 GSK-3196165
  9. 1.2.7 Others
  10. 1.3 Granulocyte Macrophage Colony Stimulating Factor Market by Application
  11. 1.3.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Solid Tumor
  13. 1.3.3 Kidney Cancer
  14. 1.3.4 Lymphoma
  15. 1.3.5 Lung Disease
  16. 1.3.6 Others
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 Granulocyte Macrophage Colony Stimulating Factor Market Dynamics
  1. 2.1 Granulocyte Macrophage Colony Stimulating Factor Industry Trends
  2. 2.2 Granulocyte Macrophage Colony Stimulating Factor Industry Drivers
  3. 2.3 Granulocyte Macrophage Colony Stimulating Factor Industry Opportunities and Challenges
  4. 2.4 Granulocyte Macrophage Colony Stimulating Factor Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Region
  3. 3.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Region (2021-2026)
  5. 3.2.3 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Region (2027-2032)
  6. 3.2.4 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Granulocyte Macrophage Colony Stimulating Factor Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Region
  9. 3.4.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Region (2021-2026)
  11. 3.4.3 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Region (2027-2032)
  12. 3.4.4 Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Manufacturers
  2. 4.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Granulocyte Macrophage Colony Stimulating Factor Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Manufacturers
  6. 4.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Granulocyte Macrophage Colony Stimulating Factor Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Granulocyte Macrophage Colony Stimulating Factor Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Granulocyte Macrophage Colony Stimulating Factor Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Granulocyte Macrophage Colony Stimulating Factor Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Granulocyte Macrophage Colony Stimulating Factor Manufacturers, Product Type & Application
  13. 4.7 Global Granulocyte Macrophage Colony Stimulating Factor Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Granulocyte Macrophage Colony Stimulating Factor Market CR5 and HHI
  16. 4.8.2 2025 Granulocyte Macrophage Colony Stimulating Factor Tier 1, Tier 2, and Tier 3
5 Granulocyte Macrophage Colony Stimulating Factor Market by Type
  1. 5.1 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Type
  2. 5.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Type
  6. 5.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2021-2032)
  9. 5.3 Global Granulocyte Macrophage Colony Stimulating Factor Price by Type
6 Granulocyte Macrophage Colony Stimulating Factor Market by Application
  1. 6.1 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Application
  2. 6.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Application
  6. 6.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2021-2032)
  9. 6.3 Global Granulocyte Macrophage Colony Stimulating Factor Price by Application
7 Company Profiles
  1. 7.1 Takeda Pharmaceutical Co Ltd
  2. 7.1.1 Takeda Pharmaceutical Co Ltd Company Information
  3. 7.1.2 Takeda Pharmaceutical Co Ltd Business Overview
  4. 7.1.3 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Product Portfolio
  6. 7.1.5 Takeda Pharmaceutical Co Ltd Recent Developments
  7. 7.2 GlaxoSmithKline Plc
  8. 7.2.1 GlaxoSmithKline Plc Company Information
  9. 7.2.2 GlaxoSmithKline Plc Business Overview
  10. 7.2.3 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Product Portfolio
  12. 7.2.5 GlaxoSmithKline Plc Recent Developments
  13. 7.3 Amgen Inc
  14. 7.3.1 Amgen Inc Company Information
  15. 7.3.2 Amgen Inc Business Overview
  16. 7.3.3 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolio
  18. 7.3.5 Amgen Inc Recent Developments
  19. 7.4 Sillajen Biotherapeutics
  20. 7.4.1 Sillajen Biotherapeutics Company Information
  21. 7.4.2 Sillajen Biotherapeutics Business Overview
  22. 7.4.3 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Product Portfolio
  24. 7.4.5 Sillajen Biotherapeutics Recent Developments
  25. 7.5 Morphotek Inc
  26. 7.5.1 Morphotek Inc Company Information
  27. 7.5.2 Morphotek Inc Business Overview
  28. 7.5.3 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolio
  30. 7.5.5 Morphotek Inc Recent Developments
  31. 7.6 Mologen AG
  32. 7.6.1 Mologen AG Company Information
  33. 7.6.2 Mologen AG Business Overview
  34. 7.6.3 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Product Portfolio
  36. 7.6.5 Mologen AG Recent Developments
  37. 7.7 Humanigen Inc
  38. 7.7.1 Humanigen Inc Company Information
  39. 7.7.2 Humanigen Inc Business Overview
  40. 7.7.3 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolio
  42. 7.7.5 Humanigen Inc Recent Developments
  43. 7.8 Cold Genesys Inc
  44. 7.8.1 Cold Genesys Inc Company Information
  45. 7.8.2 Cold Genesys Inc Business Overview
  46. 7.8.3 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolio
  48. 7.8.5 Cold Genesys Inc Recent Developments
  49. 7.9 BriaCell Therapeutics Corp
  50. 7.9.1 BriaCell Therapeutics Corp Company Information
  51. 7.9.2 BriaCell Therapeutics Corp Business Overview
  52. 7.9.3 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Product Portfolio
  54. 7.9.5 BriaCell Therapeutics Corp Recent Developments
  55. 7.10 Aduro BioTech Inc
  56. 7.10.1 Aduro BioTech Inc Company Information
  57. 7.10.2 Aduro BioTech Inc Business Overview
  58. 7.10.3 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolio
  60. 7.10.5 Aduro BioTech Inc Recent Developments
8 North America
  1. 8.1 North America Granulocyte Macrophage Colony Stimulating Factor Market Size by Type
  2. 8.1.1 North America Granulocyte Macrophage Colony Stimulating Factor Revenue by Type (2021-2032)
  3. 8.1.2 North America Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021-2032)
  4. 8.1.3 North America Granulocyte Macrophage Colony Stimulating Factor Price by Type (2021-2032)
  5. 8.2 North America Granulocyte Macrophage Colony Stimulating Factor Market Size by Application
  6. 8.2.1 North America Granulocyte Macrophage Colony Stimulating Factor Revenue by Application (2021-2032)
  7. 8.2.2 North America Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021-2032)
  8. 8.2.3 North America Granulocyte Macrophage Colony Stimulating Factor Price by Application (2021-2032)
  9. 8.3 North America Granulocyte Macrophage Colony Stimulating Factor Market Size by Country
  10. 8.3.1 North America Granulocyte Macrophage Colony Stimulating Factor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Granulocyte Macrophage Colony Stimulating Factor Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Granulocyte Macrophage Colony Stimulating Factor Market Size by Type
  2. 9.1.1 Europe Granulocyte Macrophage Colony Stimulating Factor Revenue by Type (2021-2032)
  3. 9.1.2 Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021-2032)
  4. 9.1.3 Europe Granulocyte Macrophage Colony Stimulating Factor Price by Type (2021-2032)
  5. 9.2 Europe Granulocyte Macrophage Colony Stimulating Factor Market Size by Application
  6. 9.2.1 Europe Granulocyte Macrophage Colony Stimulating Factor Revenue by Application (2021-2032)
  7. 9.2.2 Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021-2032)
  8. 9.2.3 Europe Granulocyte Macrophage Colony Stimulating Factor Price by Application (2021-2032)
  9. 9.3 Europe Granulocyte Macrophage Colony Stimulating Factor Market Size by Country
  10. 9.3.1 Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Granulocyte Macrophage Colony Stimulating Factor Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Granulocyte Macrophage Colony Stimulating Factor Market Size by Type
  2. 10.1.1 China Granulocyte Macrophage Colony Stimulating Factor Revenue by Type (2021-2032)
  3. 10.1.2 China Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021-2032)
  4. 10.1.3 China Granulocyte Macrophage Colony Stimulating Factor Price by Type (2021-2032)
  5. 10.2 China Granulocyte Macrophage Colony Stimulating Factor Market Size by Application
  6. 10.2.1 China Granulocyte Macrophage Colony Stimulating Factor Revenue by Application (2021-2032)
  7. 10.2.2 China Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021-2032)
  8. 10.2.3 China Granulocyte Macrophage Colony Stimulating Factor Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Granulocyte Macrophage Colony Stimulating Factor Market Size by Type
  2. 11.1.1 Asia Granulocyte Macrophage Colony Stimulating Factor Revenue by Type (2021-2032)
  3. 11.1.2 Asia Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021-2032)
  4. 11.1.3 Asia Granulocyte Macrophage Colony Stimulating Factor Price by Type (2021-2032)
  5. 11.2 Asia Granulocyte Macrophage Colony Stimulating Factor Market Size by Application
  6. 11.2.1 Asia Granulocyte Macrophage Colony Stimulating Factor Revenue by Application (2021-2032)
  7. 11.2.2 Asia Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021-2032)
  8. 11.2.3 Asia Granulocyte Macrophage Colony Stimulating Factor Price by Application (2021-2032)
  9. 11.3 Asia Granulocyte Macrophage Colony Stimulating Factor Market Size by Country
  10. 11.3.1 Asia Granulocyte Macrophage Colony Stimulating Factor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Granulocyte Macrophage Colony Stimulating Factor Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Granulocyte Macrophage Colony Stimulating Factor Market Size by Type
  2. 12.1.1 SAMEA Granulocyte Macrophage Colony Stimulating Factor Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Granulocyte Macrophage Colony Stimulating Factor Price by Type (2021-2032)
  5. 12.2 SAMEA Granulocyte Macrophage Colony Stimulating Factor Market Size by Application
  6. 12.2.1 SAMEA Granulocyte Macrophage Colony Stimulating Factor Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Granulocyte Macrophage Colony Stimulating Factor Price by Application (2021-2032)
  9. 12.3 SAMEA Granulocyte Macrophage Colony Stimulating Factor Market Size by Country
  10. 12.3.1 SAMEA Granulocyte Macrophage Colony Stimulating Factor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Granulocyte Macrophage Colony Stimulating Factor Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Granulocyte Macrophage Colony Stimulating Factor Value Chain Analysis
  2. 13.1.1 Granulocyte Macrophage Colony Stimulating Factor Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Granulocyte Macrophage Colony Stimulating Factor Production Mode & Process
  6. 13.2 Granulocyte Macrophage Colony Stimulating Factor Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Granulocyte Macrophage Colony Stimulating Factor Distributors
  9. 13.2.3 Granulocyte Macrophage Colony Stimulating Factor Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst